The genomic landscape of FN-RMS is more heterogeneous, with a number of potential genetic drivers being implicated in their pathogenesis, including alterations in tumor suppressor genes (BCOR, NF1, and TP53), RAS activating mutations or FGFR1 amplifications5,6. This evidence concerns the gene NF1 and neoplasm.